CD44 and breast carcinoma: It was also able to reduce the expression of c-Myc, Sox-2, and Oct4, which are stemness-associated proteins, in breast cancer cells and to decrease the proportion of CD44+/CD24− breast cancer stem cells in the tumor population, thus inhibiting tumor progression [94].